January 17, 2017
Dechra’s acquisitions deliver good half year results
Dechra has issued an unaudited Trading Update covering the half year reporting period (the Period) from 1 July to 31…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
January 17, 2017
Oxford Pharmascience studies/regulatory update for OXPzero, looks for potential partners
Oxford Pharmascience Group has completed laboratory work to identify modifications to the OXPzero technology platform that alter the release properties and enable faster release of the NSAID.
January 17, 2017
Bavarian Nordic appoints Henrik Birk as COO
Bavarian Nordic has appointed Henrik Birk as Chief Operating Officer, the newly created position where he will develop and lead the execution of Bavarian Nordic’s operational and HR strategies.
January 17, 2017
Onzima buys remaining 51% of N4 Pharma
Onzima Ventures said on Tuestday it would buy another 51% of N4 Pharma Limited shares with 34609210 new ordinary shares of of 0.1p each in its capital. The acquisition should be completed by mid-April 2017.
January 17, 2017
Sinclair tops out market expectations, sales rise 37%
Pure-play aesthetics company SInclair Pharma has reported topping out market expectations with sales in the twelve months until December 2016 being about £2m, which represents the gorwth of more than 37% to £37.8m.
January 17, 2017
Novo Nordisk sails into “Safe Harbour”, repurchases shares
Novo Nordisk has initiated a share repurchase programme in accordance with certain European regulations known as the Safe Harbour rules.
January 16, 2017
MML enters into new supply agreement with Uruguay’s CCC
Mainstay Medical International’s subsidiary Mainstay Medical Limited (MML) has made a new supply deal with Centro de Construccion de Cardioestimuladores del Uruguay S.A. (CCC)
January 16, 2017
Cresco Pharma requests trading halt
Creso Pharma Limited, the company that Creso Pharma, the company focused on cannabis derived therapeutics, requests that its securities to be placed in a trading halt.
January 16, 2017
FIT Biotech Oy’s converts convertible notes into shares
Related to Convertible Note and Warrant Programmes established on September 26, 2016 between the Fit Biotech Oy and Bracknor Investment,…
January 16, 2017
University of Michigan Pancreatic Cancer Center, Immunovia partner up in fighting pancreatic cancer
University of Michigan Pancreatic Cancer Center has become the most recent member of the global network of prominent sites participating…